Scholarlink

<p>Growth hormone-releasing peptide 6 (GHRP-6), is a six-amino acid synthetic peptide that acts as a ghrelin analog and has shown growth-promoting and immunomodulatory activities in several fish species. This study evaluates the effects of GHRP-6 against the infection with the nervous necrosis virus (NNV), an important pathogen affecting the central nervous system of a wide range of fish species, including European seabass (<i>Dicentrarchus labrax</i>). For the in vitro evaluation, E11 cells were treated with GHRP-6 before and/or during viral infection, resulting in higher cellular survival rates, lower viral genome replication, and lower production of infective viral particles compared with control cells. These results indicate that GHRP-6 protects E11 cells from the viral infection. In order to conduct the in vivo evaluation, European seabass specimens were intraperitoneally injected with GHRP-6, resulting in the significant upregulation of several immune genes, such as <i>TNF-A</i>, <i>RTP3</i>, and <i>IgM</i>, in head kidney and intestine. Furthermore, NNV replication was lower in the brain from GHRP-6 injected fish than in controls, and the brain antiviral immune response was clearly modulated in treated fish. These results support the potential of GHRP-6 as an antiviral compound that could contribute to prevent viral diseases in fish farms, a priority for the aquaculture industry.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Anti-nervous necrosis virus activity of the growth hormone releasing peptide-6, GHRP-6

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月30日

查看全文
  • Daniel Álvarez-Torres,
  • Rebeca Martínez,
  • Patricia Moreno,
  • M. Carmen Alonso,
  • Esther García-Rosado,
  • Mario P. Estrada,
  • Julia Béjar

摘要

Growth hormone-releasing peptide 6 (GHRP-6), is a six-amino acid synthetic peptide that acts as a ghrelin analog and has shown growth-promoting and immunomodulatory activities in several fish species. This study evaluates the effects of GHRP-6 against the infection with the nervous necrosis virus (NNV), an important pathogen affecting the central nervous system of a wide range of fish species, including European seabass (Dicentrarchus labrax). For the in vitro evaluation, E11 cells were treated with GHRP-6 before and/or during viral infection, resulting in higher cellular survival rates, lower viral genome replication, and lower production of infective viral particles compared with control cells. These results indicate that GHRP-6 protects E11 cells from the viral infection. In order to conduct the in vivo evaluation, European seabass specimens were intraperitoneally injected with GHRP-6, resulting in the significant upregulation of several immune genes, such as TNF-A, RTP3, and IgM, in head kidney and intestine. Furthermore, NNV replication was lower in the brain from GHRP-6 injected fish than in controls, and the brain antiviral immune response was clearly modulated in treated fish. These results support the potential of GHRP-6 as an antiviral compound that could contribute to prevent viral diseases in fish farms, a priority for the aquaculture industry.